AQST
AQST
NASDAQ · Pharmaceuticals

Aquestive Therapeutics Inc

$3.98
-0.08 (-1.97%)
As of Mar 22, 10:21 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +550.8% upside
Low Target $17.61
Average Target $25.90
High Target $34.98
Current Price $3.98
Current
$3.98
Target
$25.90
$17.61 $25.90 avg $34.98
Scenario Analysis
Bear Case
$17.61
342.5%
Low target
Base Case
$25.90
+550.8%
Avg target
Bull Case
$34.98
+778.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$7.55
-47.3% from high
52-Week Low
$2.12
+87.7% from low
Target vs 52W High
$25.90
+243.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%